Chinese General Practice ›› 2023, Vol. 26 ›› Issue (17): 2147-2154.DOI: 10.12114/j.issn.1007-9572.2022.0568
Special Issue: 肿瘤最新文章合辑
• Evidence-based Medicine • Previous Articles Next Articles
Received:
2022-06-15
Revised:
2022-10-12
Published:
2023-06-15
Online:
2022-10-31
Contact:
ZHOU Fenghai
通讯作者:
周逢海
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0568
步骤 | 检索词 |
---|---|
#1 | ( "Prostatectomy" [Title/Abstract] OR "Prostatectomies" [Title/Abstract] OR "suprapubic prostatectomies" [Title/Abstract] OR "suprapubic prostatectomy " [Title/Abstract] OR "retropubic prostatectomies" [Title/Abstract] OR "retropubic prostatectomy" [Title/Abstract] OR "radical prostatectomy" [Title/Abstract] OR(( "radical" [All Fields] OR "radical's" [All Fields] OR "radicals" [All Fields]) AND( "resect" [All Fields] OR "resectability" [All Fields] OR "resectable" [All Fields] OR "resectates" [All Fields] OR "resected" [All Fields] OR "resecting" [All Fields] OR "Resection" [All Fields] OR "resectional" [All Fields] OR "resectioned" [All Fields] OR "resectioning" [All Fields] OR "resections" [All Fields] OR "resective" [All Fields] OR "resects" [All Fields]) AND " prostate cancer" [Title/Abstract])) |
#2 | ( "positive margin" [Title/Abstract] OR "positive excision margins" [Title/Abstract] OR "margins of excision" [Title/Abstract] OR "excision margin" [Title/Abstract] OR "excision margins" [Title/Abstract] OR "resection margin" [Title/Abstract] OR "resection margins" [Title/Abstract] OR "surgical margins" [Title/Abstract] OR "surgical margin" [Title/Abstract] OR "positive surgical margins" [Title/Abstract] OR "positive surgical margin" [Title/Abstract] OR "negative surgical margins" [Title/Abstract] OR "negative surgical margin" [Title/Abstract] OR "tumor free margins" [Title/Abstract] OR "tumor free margins" [Title/Abstract] OR "tumor free margin" [Title/Abstract]) |
#3 | ( "Risk factors" [Title/Abstract] OR "social risk factors" [Title/Abstract] OR "social risk factor" [Title/Abstract] OR "health correlates" [Title/Abstract] OR "population at risk" [Title/Abstract] OR "populations at risk" [Title/Abstract] OR "risk scores" [Title/Abstract] OR "risk score" [Title/Abstract] OR "risk factor scores" [Title/Abstract] OR "risk factor score" [Title/Abstract] OR "dangerous factor" [Title/Abstract] OR "hazardous factors" [Title/Abstract] OR "risky factors" [Title/Abstract] OR "risks factors" [Title/Abstract] OR "Risk-factors" [Title/Abstract] OR "danger factors" [Title/Abstract] OR "danger factor" [Title/Abstract] OR "hazard factors" [Title/Abstract] OR "Factor" [Title/Abstract] OR "Factors" [Title/Abstract] OR " elements" [Title/Abstract] OR "element" [Title/Abstract]) |
#4 | #1 AND #2 AND #3 |
Table 1 Strategy for searching studies
步骤 | 检索词 |
---|---|
#1 | ( "Prostatectomy" [Title/Abstract] OR "Prostatectomies" [Title/Abstract] OR "suprapubic prostatectomies" [Title/Abstract] OR "suprapubic prostatectomy " [Title/Abstract] OR "retropubic prostatectomies" [Title/Abstract] OR "retropubic prostatectomy" [Title/Abstract] OR "radical prostatectomy" [Title/Abstract] OR(( "radical" [All Fields] OR "radical's" [All Fields] OR "radicals" [All Fields]) AND( "resect" [All Fields] OR "resectability" [All Fields] OR "resectable" [All Fields] OR "resectates" [All Fields] OR "resected" [All Fields] OR "resecting" [All Fields] OR "Resection" [All Fields] OR "resectional" [All Fields] OR "resectioned" [All Fields] OR "resectioning" [All Fields] OR "resections" [All Fields] OR "resective" [All Fields] OR "resects" [All Fields]) AND " prostate cancer" [Title/Abstract])) |
#2 | ( "positive margin" [Title/Abstract] OR "positive excision margins" [Title/Abstract] OR "margins of excision" [Title/Abstract] OR "excision margin" [Title/Abstract] OR "excision margins" [Title/Abstract] OR "resection margin" [Title/Abstract] OR "resection margins" [Title/Abstract] OR "surgical margins" [Title/Abstract] OR "surgical margin" [Title/Abstract] OR "positive surgical margins" [Title/Abstract] OR "positive surgical margin" [Title/Abstract] OR "negative surgical margins" [Title/Abstract] OR "negative surgical margin" [Title/Abstract] OR "tumor free margins" [Title/Abstract] OR "tumor free margins" [Title/Abstract] OR "tumor free margin" [Title/Abstract]) |
#3 | ( "Risk factors" [Title/Abstract] OR "social risk factors" [Title/Abstract] OR "social risk factor" [Title/Abstract] OR "health correlates" [Title/Abstract] OR "population at risk" [Title/Abstract] OR "populations at risk" [Title/Abstract] OR "risk scores" [Title/Abstract] OR "risk score" [Title/Abstract] OR "risk factor scores" [Title/Abstract] OR "risk factor score" [Title/Abstract] OR "dangerous factor" [Title/Abstract] OR "hazardous factors" [Title/Abstract] OR "risky factors" [Title/Abstract] OR "risks factors" [Title/Abstract] OR "Risk-factors" [Title/Abstract] OR "danger factors" [Title/Abstract] OR "danger factor" [Title/Abstract] OR "hazard factors" [Title/Abstract] OR "Factor" [Title/Abstract] OR "Factors" [Title/Abstract] OR " elements" [Title/Abstract] OR "element" [Title/Abstract]) |
#4 | #1 AND #2 AND #3 |
第一作者 | 发表年份(年) | 研究地区 | 样本量(例) | 手术方式 | 结局指标 | NOS评分(分) | |
---|---|---|---|---|---|---|---|
病例组 | 对照组 | ||||||
张靖博[ | 2021 | 河南 | 64 | 188 | LRP | ①②⑦⑧ | 8 |
张平新[ | 2020 | 新疆 | 26 | 73 | LRP | ⑧ | 6 |
阎乙夫[ | 2011 | 北京 | 76 | 112 | LRP | ⑦⑧ | 8 |
陈星[ | 2021 | 福建 | 36 | 86 | LRP | ①③④⑦⑧ | 7 |
张争[ | 2019 | 北京 | 57 | 120 | LRP | ⑧ | 7 |
吴丹[ | 2020 | 江苏 | 34 | 82 | LRP | ⑧ | 6 |
缪志俊[ | 2021 | 江苏 | 79 | 420 | LRP | ①③⑤ | 7 |
王硕[ | 2021 | 北京 | 97 | 83 | — | ⑦⑧ | 8 |
侯惠民[ | 2018 | 北京 | 94 | 226 | — | ② | 7 |
范效铮[ | 2021 | 陕西 | 158 | 360 | RARP | ①⑤ | 8 |
屈武功[ | 2021 | 河南 | 106 | 204 | RARP | ② | 7 |
张春雷[ | 2018 | 上海 | 47 | 143 | RARP | ①⑧ | 7 |
沈诞[ | 2012 | 上海 | 258 | 1 390 | RARP | ⑤ | 7 |
瞿旻[ | 2017 | 上海 | 151 | 249 | RARP | ①⑤ | 8 |
韩涛[ | 2013 | 江苏 | 98 | 162 | LRP | ④⑥ | 6 |
张铁龙[ | 2015 | 上海 | 61 | 184 | ORP | ①⑦ | 6 |
丁攀[ | 2019 | 江西 | 118 | 114 | — | ①②④⑥ | 7 |
洪锴[ | 2008 | 北京 | 9 | 24 | LRP | ⑤⑦ | 7 |
YANG[ | 2017 | 江苏 | 86 | 210 | LRP | ③④⑥ | 7 |
WANG[ | 2021 | 北京 | 106 | 94 | — | ④⑤ | 8 |
ZHOU[ | 2021 | 天津 | 267 | 230 | — | ①⑦ | 8 |
Table 2 Table of basic characteristics and risk of bias in included studies
第一作者 | 发表年份(年) | 研究地区 | 样本量(例) | 手术方式 | 结局指标 | NOS评分(分) | |
---|---|---|---|---|---|---|---|
病例组 | 对照组 | ||||||
张靖博[ | 2021 | 河南 | 64 | 188 | LRP | ①②⑦⑧ | 8 |
张平新[ | 2020 | 新疆 | 26 | 73 | LRP | ⑧ | 6 |
阎乙夫[ | 2011 | 北京 | 76 | 112 | LRP | ⑦⑧ | 8 |
陈星[ | 2021 | 福建 | 36 | 86 | LRP | ①③④⑦⑧ | 7 |
张争[ | 2019 | 北京 | 57 | 120 | LRP | ⑧ | 7 |
吴丹[ | 2020 | 江苏 | 34 | 82 | LRP | ⑧ | 6 |
缪志俊[ | 2021 | 江苏 | 79 | 420 | LRP | ①③⑤ | 7 |
王硕[ | 2021 | 北京 | 97 | 83 | — | ⑦⑧ | 8 |
侯惠民[ | 2018 | 北京 | 94 | 226 | — | ② | 7 |
范效铮[ | 2021 | 陕西 | 158 | 360 | RARP | ①⑤ | 8 |
屈武功[ | 2021 | 河南 | 106 | 204 | RARP | ② | 7 |
张春雷[ | 2018 | 上海 | 47 | 143 | RARP | ①⑧ | 7 |
沈诞[ | 2012 | 上海 | 258 | 1 390 | RARP | ⑤ | 7 |
瞿旻[ | 2017 | 上海 | 151 | 249 | RARP | ①⑤ | 8 |
韩涛[ | 2013 | 江苏 | 98 | 162 | LRP | ④⑥ | 6 |
张铁龙[ | 2015 | 上海 | 61 | 184 | ORP | ①⑦ | 6 |
丁攀[ | 2019 | 江西 | 118 | 114 | — | ①②④⑥ | 7 |
洪锴[ | 2008 | 北京 | 9 | 24 | LRP | ⑤⑦ | 7 |
YANG[ | 2017 | 江苏 | 86 | 210 | LRP | ③④⑥ | 7 |
WANG[ | 2021 | 北京 | 106 | 94 | — | ④⑤ | 8 |
ZHOU[ | 2021 | 天津 | 267 | 230 | — | ①⑦ | 8 |
危险因素 | 纳入研究数(篇) | 异质性分析结果 | 效应模型 | Meta分析结果 | ||
---|---|---|---|---|---|---|
I2值(%) | P值 | OR(95%CI) | P值 | |||
LRP | ||||||
术前PSA | 3[ | 87.7 | <0.001 | 随机效应模型 | 1.47(0.42,5.09) | 0.548 |
穿刺阳性针数 | 3[ | 84.3 | 0.002 | 随机效应模型 | 2.17(0.98,4.80) | 0.057 |
术前临床T分期 | 2[ | 43.9 | 0.182 | 固定效应模型 | 4.57(2.57,8.12) | <0.001 |
术后病理T分期 | 6[ | 79.2 | <0.001 | 随机效应模型 | 4.80(2.20,10.48) | <0.001 |
术后Gleason评分 | 3[ | 0 | 0.739 | 固定效应模型 | 2.46(1.57,3.86) | <0.001 |
RARP | ||||||
术前PSA | 3[ | 22.4 | 0.275 | 固定效应模型 | 2.17(1.60,2.94) | <0.001 |
术前临床T分期 | 3[ | 81.6 | 0.004 | 随机效应模型 | 1.19(0.52,2.74) | 0.678 |
Table 3 Subgroup analysis of different risk factors for PSMs after radical prostatectomy
危险因素 | 纳入研究数(篇) | 异质性分析结果 | 效应模型 | Meta分析结果 | ||
---|---|---|---|---|---|---|
I2值(%) | P值 | OR(95%CI) | P值 | |||
LRP | ||||||
术前PSA | 3[ | 87.7 | <0.001 | 随机效应模型 | 1.47(0.42,5.09) | 0.548 |
穿刺阳性针数 | 3[ | 84.3 | 0.002 | 随机效应模型 | 2.17(0.98,4.80) | 0.057 |
术前临床T分期 | 2[ | 43.9 | 0.182 | 固定效应模型 | 4.57(2.57,8.12) | <0.001 |
术后病理T分期 | 6[ | 79.2 | <0.001 | 随机效应模型 | 4.80(2.20,10.48) | <0.001 |
术后Gleason评分 | 3[ | 0 | 0.739 | 固定效应模型 | 2.46(1.57,3.86) | <0.001 |
RARP | ||||||
术前PSA | 3[ | 22.4 | 0.275 | 固定效应模型 | 2.17(1.60,2.94) | <0.001 |
术前临床T分期 | 3[ | 81.6 | 0.004 | 随机效应模型 | 1.19(0.52,2.74) | 0.678 |
危险因素 | 随机效应模型 | 固定效应模型 | ||
---|---|---|---|---|
OR(95%CI) | P值 | OR(95%CI) | P值 | |
术前PSA | 1.77(1.18,2.65) | 0.006 | 1.05(1.02,1.08) | <0.001 |
穿刺阳性针数百分比 | 1.83(1.35,2.47) | <0.001 | 1.83(1.35,2.47) | <0.001 |
穿刺阳性针数 | 2.17(0.98,4.80) | 0.057 | 1.24(1.14,1.34) | <0.001 |
穿刺Gleason评分 | 2.25(1.63,3.10) | <0.001 | 2.14(1.67,2.74) | <0.001 |
穿刺神经周围侵犯 | 5.83(2.05,16.59) | 0.001 | 6.09(4.04,9.17) | <0.001 |
术前临床T分期 | 2.17(1.06,4.42) | 0.033 | 2.08(1.58,2.74) | <0.001 |
术后病理T分期 | 4.30(2.43,7.63) | <0.001 | 2.98(2.28,3.88) | <0.001 |
术后Gleason评分 | 2.55(1.75,3.72) | <0.001 | 2.33(1.80,3.01) | <0.001 |
Table 4 Sensitivity analysis of risk factors for PSMs after radical prostatectomy in Chinese men
危险因素 | 随机效应模型 | 固定效应模型 | ||
---|---|---|---|---|
OR(95%CI) | P值 | OR(95%CI) | P值 | |
术前PSA | 1.77(1.18,2.65) | 0.006 | 1.05(1.02,1.08) | <0.001 |
穿刺阳性针数百分比 | 1.83(1.35,2.47) | <0.001 | 1.83(1.35,2.47) | <0.001 |
穿刺阳性针数 | 2.17(0.98,4.80) | 0.057 | 1.24(1.14,1.34) | <0.001 |
穿刺Gleason评分 | 2.25(1.63,3.10) | <0.001 | 2.14(1.67,2.74) | <0.001 |
穿刺神经周围侵犯 | 5.83(2.05,16.59) | 0.001 | 6.09(4.04,9.17) | <0.001 |
术前临床T分期 | 2.17(1.06,4.42) | 0.033 | 2.08(1.58,2.74) | <0.001 |
术后病理T分期 | 4.30(2.43,7.63) | <0.001 | 2.98(2.28,3.88) | <0.001 |
术后Gleason评分 | 2.55(1.75,3.72) | <0.001 | 2.33(1.80,3.01) | <0.001 |
危险因素 | 排除文献 | 排除前 | 排除后 | ||||
---|---|---|---|---|---|---|---|
模型 | OR(95%CI) | P值 | 模型 | OR(95%CI) | P值 | ||
术前PSA | [ | 随机效应模型 | 1.77(1.18,2.65) | 0.006 | 固定效应模型 | 2.31(1.88,2.83) | <0.001 |
穿刺阳性针数 | [ | 随机效应模型 | 2.17(0.98,4.80) | 0.057 | 固定效应模型 | 3.09(1.81,5.26) | <0.001 |
穿刺神经周围侵犯 | [ | 随机效应模型 | 5.83(2.05,16.59) | 0.001 | 固定效应模型 | 3.79(2.30,6.24) | <0.001 |
术前临床T分期 | [ | 随机效应模型 | 2.17(1.06,4.42) | 0.033 | 固定效应模型 | 1.95(1.41,2.71) | <0.001 |
术后病理T分期 | [ | 随机效应模型 | 4.30(2.43,7.63) | <0.001 | 固定效应模型 | 3.77(2.58,5.51) | <0.001 |
Table 5 Exclusion analysis of risk factors for PSMs after radical prostatectomy in Chinese men
危险因素 | 排除文献 | 排除前 | 排除后 | ||||
---|---|---|---|---|---|---|---|
模型 | OR(95%CI) | P值 | 模型 | OR(95%CI) | P值 | ||
术前PSA | [ | 随机效应模型 | 1.77(1.18,2.65) | 0.006 | 固定效应模型 | 2.31(1.88,2.83) | <0.001 |
穿刺阳性针数 | [ | 随机效应模型 | 2.17(0.98,4.80) | 0.057 | 固定效应模型 | 3.09(1.81,5.26) | <0.001 |
穿刺神经周围侵犯 | [ | 随机效应模型 | 5.83(2.05,16.59) | 0.001 | 固定效应模型 | 3.79(2.30,6.24) | <0.001 |
术前临床T分期 | [ | 随机效应模型 | 2.17(1.06,4.42) | 0.033 | 固定效应模型 | 1.95(1.41,2.71) | <0.001 |
术后病理T分期 | [ | 随机效应模型 | 4.30(2.43,7.63) | <0.001 | 固定效应模型 | 3.77(2.58,5.51) | <0.001 |
Figure 11 The funnel plot assessing potential publication bias for the meta-analysis of the impact of pre-radical prostatectomy clinical T stage on PSMs
Figure 12 The funnel plot assessing potential publication bias for the meta-analysis of the impact of post-radical prostatectomy pathological T stage on PSMs
Figure 13 The funnel plot assessing potential publication bias for the meta-analysis of the impact of post-radical prostatectomy Gleason score on PSMs
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
张靖博. 腹膜外途径腹腔镜下根治性前列腺切除术切缘阳性的影响因素分析[J]. 中国现代医药杂志,2021,23(3):33-36. DOI:10.3969/j.issn.1672-9463.2021.03.008.
|
[6] |
张平新,王文光,马军,等. 腹膜外途径腹腔镜下根治性前列腺切除术切缘阳性的影响因素[J]. 现代泌尿外科杂志,2020,25(3):247-251.
|
[7] |
阎乙夫,黄毅,马潞林. 腹腔镜根治性前列腺切除术后切缘阳性的相关因素分析[J]. 临床泌尿外科杂志,2011,26(12):901-905. DOI:10.3969/j.issn.1001-1420.2011.12.006.
|
[8] |
陈星,李炤,何裕杰. 腹腔镜前列腺癌根治术后切缘阳性的影响因素及对患者术后生化复发的影响[J]. 医学理论与实践,2021,34(21):3742-3744. DOI:10.19381/j.issn.1001-7585.2021.21.023.
|
[9] |
张争,张克楠,洪保安,等. 腹腔镜前列腺癌根治术后切缘阳性的相关影响因素分析[J]. 中国肿瘤临床,2019,46(6):299-302. DOI:10.3969/j.issn.1000-8179.2019.06.276.
|
[10] |
吴丹. 腹腔镜前列腺癌根治术围手术期指标影响因素分析[D]. 苏州:苏州大学,2020.
|
[11] |
缪志俊,李鹏,徐宏博,等. 腹腔镜下前列腺癌根治术后切缘阳性的危险因素分析[J]. 现代泌尿生殖肿瘤杂志,2021,13(5):274-277.
|
[12] |
王硕,杜鹏,曹煜东,等. 根治性前列腺切除术后前列腺尖端、基底切缘阳性的危险因素分析[J]. 中华泌尿外科杂志,2021,42(4):283-288. DOI:10.3760/cma.j.cn112330-20210106-00008.
|
[13] |
侯惠民,江炘,刘明,等. 根治性前列腺切除术后切缘阳性的临床特征和影响因素分析[J]. 中华泌尿外科杂志,2018,39(10):740-744. DOI:10.3760/cma.j.issn.1000-6702.2018.10.004.
|
[14] |
范效铮,权鹏鹤,张龙龙,等. 机器人辅助腹腔镜根治性前列腺切除术患者特征及切缘阳性分析[J]. 微创泌尿外科杂志,2021,10(2):105-110. DOI:10.19558/j.cnki.10-1020/r.2021.02.007.
|
[15] |
屈武功,董彪,陶金,等. 机器人辅助腹腔镜根治性前列腺切除术后切缘阳性的影响因素分析[J]. 中华泌尿外科杂志,2021,42(4):289-293. DOI:10.3760/cma.j.cn112330-20200430-00338.
|
[16] |
张春雷,陈锐,孔德沛,等. 机器人辅助腹腔镜根治性前列腺切除术后切缘阳性和生化复发的影响因素及相关性分析[J]. 中华泌尿外科杂志,2018,39(12):905-910. DOI:10.3760/cma.j.issn.1000-6702.2018.12.006.
|
[17] |
沈诞. 机器人辅助腹腔镜前列腺癌根治术治疗高危前列腺癌的研究[D]. 上海:第二军医大学,2012.
|
[18] |
瞿旻,林恒之,王海峰,等. 机器人辅助腹腔镜下根治性前列腺切除术治疗高危前列腺癌400例报告[J]. 中华泌尿外科杂志,2017,38(6):424-427. DOI:10.3760/cma.j.issn.1000-6702.2017.06.007.
|
[19] |
韩涛. 前列腺癌穿刺活检与根治切除病理的相关性研究[D]. 南京:南京大学,2013.
|
[20] |
张铁龙. 前列腺癌患者临床资料库的建立及数据分析[D]. 上海:上海交通大学,2015.
|
[21] |
丁攀. 前列腺癌根治术后切缘阳性的相关因素分析及风险预测[D]. 南昌:南昌大学,2019.
|
[22] |
洪锴,马潞林,黄毅,等. 腹腔镜下前列腺癌根治术后切缘阳性的相关因素分析[J]. 中华泌尿外科杂志,2008,29(4):271-274. DOI:10.3321/j.issn:1000-6702.2008.04.015.
|
[23] |
|
[24] |
|
[25] |
|
[26] |
闫厚煜,邢金春,张开颜,等. 前列腺癌的早期诊断研究进展[J]. 临床泌尿外科杂志,2020,35(3):242-246. DOI:10.13201/j.issn.1001-1420.2020.03.018.
|
[27] |
|
[28] |
|
[29] |
赫捷,陈万青,李霓,等. 中国前列腺癌筛查与早诊早治指南(2022,北京)[J]. 中华肿瘤杂志,2022,44(1):29-53. DOI:10.3760/cma.j.cn112152-20211226-00975.
|
[30] |
|
[31] |
|
[32] |
|
[33] |
|
[34] |
|
[35] |
宫正,李艺,刘重远,等. 骨盆径线及其他相关参数与前列腺癌根治术后尖部切缘阳性关系的探讨[J]. 现代肿瘤医学,2018,26(24):3973-3977.
|
[36] |
梁迎春,许宁,吴宇鹏,等. 前列腺尖部形态对腹腔镜根治性前列腺切除术后尖部切缘阳性及生化复发的影响[J]. 中华外科杂志,2019,57(3):200-205. DOI:10.3760/cma.j.issn.0529-5815.2019.03.008.
|
[1] | XU Jialan, YAN Hong, WEN Jun, ZHOU Zitong, WANG Siyu. Prevalence of Potentially Inappropriate Medication in Older Adults with Cancer: a Meta-analysis [J]. Chinese General Practice, 2025, 28(30): 3815-3822. |
[2] | XU Baichuan, WANG Yan, ZHANG Peng, LI Yiting, LIU Feilai, XIE Yang. Research and Analysis of Screening Tools for Chronic Obstructive Pulmonary Disease Comorbidity Lung Cancer [J]. Chinese General Practice, 2025, 28(30): 3847-3852. |
[3] | SHAO Xiaoying, SHAO Jie, ZHU Yan, SHAO Jinling, SHANG Ling, WU Zhenlian, ZHAO Yu, ZHANG Jiacai. Analysis of the Current Status of Iron Deficiency and Factors Affecting Iron Deficiency Anemia among Children Aged 6-36 Months in Guizhou Province [J]. Chinese General Practice, 2025, 28(27): 3368-3374. |
[4] | ZHANG Tianyu, YU Haibo, CHEN Fei, LI Xin, ZHANG Jiajia, ZHAN Xiaokai, SHEN Man, TANG Ran, FAN Sibin, ZHAO Fengyi, HUANG Zhongxia. Meta-analysis of the Efficacy and Safety of Systemic Treatment for POEMS Syndrome [J]. Chinese General Practice, 2025, 28(27): 3447-3455. |
[5] | QUAN Jialin, ZHU Lin, SU Yu, CHEN Zekai, CHEN Ziqi, ZHANG Zhuofan. Research on the Improvement Effect of Exercise Modes on the Executive Function of Overweight or Obese Children or Adolescents: a Network Meta-analysis [J]. Chinese General Practice, 2025, 28(27): 3422-3431. |
[6] | JIANG Shihua, ZHU Zheng, REN Yingying, ZHU Yaolei, WANG Yue, GAO Xibin. Meta Analysis of the Prevalence and Risk Factors of Myopia in Chinese Children and Adolescents [J]. Chinese General Practice, 2025, 28(24): 3043-3052. |
[7] | LI Hao, LI Jiangtao, LIU Dan, WANG Jianjun. Efficacy and Safety of Belimumab, Anifrolumab, and Telitacicept on the Treatment of Systemic Lupus Erythematosus: a Network Meta-analysis [J]. Chinese General Practice, 2025, 28(23): 2924-2933. |
[8] | WANG Xiaolin, LI Qiuyue, ZHOU Yanjun, ZHANG Jinhui, LIANG Tao. Incidence and Risk of Cardiovascular Toxicity with Fruquintinib in Metastatic Colorectal Cancer: a Meta-analysis [J]. Chinese General Practice, 2025, 28(23): 2934-2940. |
[9] | ZHOU Qian, WU Xiaomin, WANG Baohua, YAN Ruohan, YU Miao, WU Jing. Study on Nomogram Prediction Model for Risk of Gastric Cancer [J]. Chinese General Practice, 2025, 28(23): 2870-2877. |
[10] | MA Panpan, WANG Sijing, YOU Na, DING Dafa, LU Yibing. Efficacy and Safety of Danuglipron and Orforglipron in the Treatment of Type 2 Diabetes Mellitus: a Meta-analysis [J]. Chinese General Practice, 2025, 28(21): 2679-2685. |
[11] | HU Wanqin, YU Shenyan, CAO Xuehua, XIANG Feng, JIA Yu. Factors Associated with Precocious Puberty in Chinese Children: a Meta-analysis [J]. Chinese General Practice, 2025, 28(21): 2661-2671. |
[12] | ADILI Tuersun, CHENG Gang. Meta-analysis of the Efficacy and Safety of Finerenone in the Treatment of Type 2 Diabetic Nephropathy [J]. Chinese General Practice, 2025, 28(21): 2686-2691. |
[13] | GUO Shengteng, ZHANG Fenfen, WAN Di, YU Dongmei, WANG Qinghua. Risk Factors for Severe Acute Pancreatitis Complicated with Acute Lung Injury: a Meta-analysis [J]. Chinese General Practice, 2025, 28(20): 2546-2554. |
[14] | WANG Biqing, ZHANG Ping, YANG Hongxia, WANG Qian, JU Chunxiao, ZHAO Junnan, MEI Jun, ZHANG Ying, XU Fengqin. Meta-analysis of Prevalence and Development Trend of Mild Cognitive Impairment in Elderly Hypertensive Patients in China [J]. Chinese General Practice, 2025, 28(17): 2186-2192. |
[15] | FAN Yu, LI Rong, GONG Shuangying, YANG Xiaojuan, LI Rui. Meta-analysis of the Incidence of Postpartum Depression among Maternal Spouses in China [J]. Chinese General Practice, 2025, 28(17): 2179-2185. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||